BackCapricor Therapeutics Overview

Capricor Therapeutics Receivables

Track Capricor Therapeutics's receivables ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00
↓ 100.00% YoYΔ $-59509.00 vs prior year quarter

Peer trimmed avg / median

Loading

Capricor Therapeutics Receivables History

Loading

Capricor Therapeutics vs. peers: Receivables Comparison

Loading

Capricor Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Capricor Therapeutics (CAPR) FAQ

The latest receivables for CAPR is $0 as of June 2026. That compares with $60K in the prior-year period — down 100.0% year over year. Investors often review this figure alongside Capricor Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, CAPR's receivables moved from $60K to $0 — a 100.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Capricor Therapeutics's operating scale or balance-sheet position.

A receivables figure of $0 for CAPR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CAPR's receivables ($0), review year-over-year change from $60K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Capricor Therapeutics's receivables against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.